Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Revision in business model in Latin America29-03-2024
29-03-2024
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Acquisition
To consolidate Strides, South Africa with Trinity Pharma, South Africa, larger step-down subsidiary of Strides group29-03-2024
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of the Notice of Postal Ballot29-03-2024
Strides Pharma Science Ltd - 532531 - Outcome Of Appeal At Hon''ble National Company Law Appellate Tribunal, New Delhi - Corporate Insolvency Process Against Strides Alathur Stands Stayed
Outcome of Appeal at Hon''ble National Company Law Appellate Tribunal, New Delhi - Corporate Insolvency Process against Strides Alathur stands stayed28-03-2024
Strides Pharma Science Ltd - 532531 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Appointment of Mr. Ameet P Hariani as Independent Director of the Company28-03-2024
Strides Pharma Science Ltd - 532531 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Read With SEBI Circular No. SEBI/ HO/ CFD/ Cfdpod- 1/ P/ CIR/ 2023/ 123 Dated July 13, 2023
Intimation under Regulation 30 (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. SEBI/ HO/ CFD/ CFDPoD - 1/ P/ CIR/ 2023/ 123 dated July 13, 202327-03-2024
Strides Pharma Science Ltd - 532531 - Intimation Under Regulation 30 Of SEBI LODR
Intimation under Regulation 30 of SEBI LODR26-03-2024
Strides Pharma Science Ltd - 532531 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd21-03-2024
Strides Pharma Science Ltd - 532531 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 - Venkat Seetharama18-03-2024
Strides Pharma Science Ltd - 532531 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication08-03-2024